Identifying Anticancer Metabolites Using Computational Methods
Author Information
Author(s): Arakaki Adrian K, Mezencev Roman, Bowen Nathan J, Huang Ying, McDonald John F, Skolnick Jeffrey
Primary Institution: Georgia Institute of Technology
Hypothesis
Up or down regulation in cancer cells of the expression of genes encoding for metabolic enzymes leads to changes in intracellular metabolite concentrations that contribute to disease progression.
Conclusion
The study demonstrates that certain metabolites can inhibit cancer cell growth, suggesting potential therapeutic targets.
Supporting Evidence
- All nine metabolites predicted to be lowered in Jurkat cells exhibited antiproliferative activity.
- Only two of the eleven tested metabolites predicted to be increased or unchanged in Jurkat cells displayed significant antiproliferative activity.
- The fraction of metabolites with known anticancer activity among those predicted to be lowered in Jurkat cells is significantly higher than those predicted to be increased.
Takeaway
The researchers found that some natural substances in the body can stop cancer cells from growing, which could help in creating new cancer treatments.
Methodology
The study used a computational method called CoMet to predict metabolite levels in cancer cells and tested the effects of selected metabolites on cell growth.
Potential Biases
Negative results may be underreported, complicating the assessment of metabolites that lack anticancer properties.
Limitations
The study's predictions about metabolite levels need to be validated with direct biochemical assays, which are currently unfeasible.
Participant Demographics
The study focused on Jurkat T leukemia cells, derived from an acute T lymphoblastic leukemia patient.
Statistical Information
P-Value
8.7 × 10-6
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website